CXCR3 and COVID-19: Collectively, the ligand-receptor pair of PF4_CXCR3, in the interaction between CD14+ monocyte and HLA_DR+ Tregs, facilitates the suppression of HLA_DR+ Tregs in severe COVID-19 patients.